Cel AI (CLAI) Competitors GBX 0.16 0.00 (-0.63%) As of 04/17/2025 11:43 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock CLAI vs. CBX, BYOT, ULVR, RKT, PZC, W7L, MCB, ACRL, REVB, and SKINShould you be buying Cel AI stock or one of its competitors? The main competitors of Cel AI include Cellular Goods (CBX), Byotrol (BYOT), Unilever (ULVR), Reckitt Benckiser Group (RKT), PZ Cussons (PZC), Warpaint London (W7L), McBride (MCB), Accrol Group (ACRL), Revolution Beauty Group (REVB), and DeepVerge plc (SKIN.L) (SKIN). These companies are all part of the "household & personal products" industry. Cel AI vs. Cellular Goods Byotrol Unilever Reckitt Benckiser Group PZ Cussons Warpaint London McBride Accrol Group Revolution Beauty Group DeepVerge plc (SKIN.L) Cel AI (LON:CLAI) and Cellular Goods (LON:CBX) are both small-cap consumer defensive companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, community ranking, analyst recommendations, profitability, media sentiment, valuation, institutional ownership, earnings and dividends. Does the media favor CLAI or CBX? In the previous week, Cel AI's average media sentiment score of 0.00 equaled Cellular Goods'average media sentiment score. Company Overall Sentiment Cel AI Neutral Cellular Goods Neutral Which has more volatility and risk, CLAI or CBX? Cel AI has a beta of -1.6, meaning that its stock price is 260% less volatile than the S&P 500. Comparatively, Cellular Goods has a beta of -1.39, meaning that its stock price is 239% less volatile than the S&P 500. Is CLAI or CBX more profitable? Cellular Goods has a net margin of 0.00% compared to Cel AI's net margin of -3,892.32%. Cellular Goods' return on equity of -93.04% beat Cel AI's return on equity.Company Net Margins Return on Equity Return on Assets Cel AI-3,892.32% -193.35% -50.24% Cellular Goods N/A -93.04%-54.98% Which has better earnings & valuation, CLAI or CBX? Cel AI has higher revenue and earnings than Cellular Goods. Cel AI is trading at a lower price-to-earnings ratio than Cellular Goods, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCel AI£57.18K15.60-£2.23M-£0.42-0.38Cellular Goods£13.06K0.00-£3.31M-£0.01N/A Does the MarketBeat Community favor CLAI or CBX? Cel AI and Cellular Goods both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformCel AIN/AN/ACellular GoodsN/AN/A SummaryCel AI and Cellular Goods tied by winning 4 of the 8 factors compared between the two stocks. Get Cel AI News Delivered to You Automatically Sign up to receive the latest news and ratings for CLAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLAI vs. The Competition Export to ExcelMetricCel AIHousehold & Personal Products IndustryDefensive SectorLON ExchangeMarket Cap£892,000.00£15.93B£6.82B£2.48BDividend YieldN/A2.45%3.16%4.96%P/E Ratio-0.3816.3710.90129.79Price / Sales15.60243.4775.13232,042.12Price / CashN/A17.16147.7728.11Price / Book1.642.772.864.39Net Income-£2.23M£912.33M£1.01B£5.83B1 Month Performance-17.37%-3.05%1.27%-1.36%1 Year PerformanceN/A85.82%47.71%40.82% Cel AI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLAICel AIN/AGBX 0.16-0.6%N/AN/A£892,000.00£57,175.59-0.385Gap DownCBXCellular GoodsN/AN/AN/AN/A£2.26M£13,058.00-37.505Gap UpBYOTByotrolN/AN/AN/AN/A£454,000.00£4.38M-22.0036Gap UpHigh Trading VolumeULVRUnilever0.7791 of 5 starsGBX 4,586.84+1.9%GBX 4,686.67+2.2%+27.5%£135.45B£70.72B20.75148,000News CoverageHigh Trading VolumeRKTReckitt Benckiser Group0.4159 of 5 starsGBX 4,760-0.8%GBX 4,788.50+0.6%+18.6%£32.48B£13.78B21.7826,000PZCPZ Cussons2.3167 of 5 starsGBX 72.20+0.7%GBX 120+66.2%-14.7%£304.30M£530.68M-5.352,644News CoverageGap UpW7LWarpaint LondonN/AGBX 360+5.9%GBX 680+88.9%-15.1%£285.33M£101.21M15.96141Gap UpMCBMcBrideN/AGBX 132-0.3%N/A+27.2%£226.27M£930.83M6.74240ACRLAccrol GroupN/AN/AN/AN/A£124.36M£221.16M-3,900.00456REVBRevolution Beauty GroupN/AGBX 11.70-1.7%N/A-69.7%£37.42M£173.87M-68.1910SKINDeepVerge plc (SKIN.L)N/AN/AN/AN/A£31.79M£1.48M-12.731,030High Trading Volume Related Companies and Tools Related Companies CBX Alternatives BYOT Alternatives ULVR Alternatives RKT Alternatives PZC Alternatives W7L Alternatives MCB Alternatives ACRL Alternatives REVB Alternatives SKIN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:CLAI) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cel AI PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Cel AI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.